107 related articles for article (PubMed ID: 24038938)
41. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
[TBL] [Abstract][Full Text] [Related]
42. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Olivier M; Langerød A; Carrieri P; Bergh J; Klaar S; Eyfjord J; Theillet C; Rodriguez C; Lidereau R; Bièche I; Varley J; Bignon Y; Uhrhammer N; Winqvist R; Jukkola-Vuorinen A; Niederacher D; Kato S; Ishioka C; Hainaut P; Børresen-Dale AL
Clin Cancer Res; 2006 Feb; 12(4):1157-67. PubMed ID: 16489069
[TBL] [Abstract][Full Text] [Related]
43. TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis.
Neves Filho EH; Cordeiro DE; Vieira AP; Rabenhorst SH
Pathobiology; 2012; 79(6):323-8. PubMed ID: 22688387
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
45. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
[TBL] [Abstract][Full Text] [Related]
46. Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors.
el Bahtimi R; Hazen-Martin DJ; Re GG; Willingham MC; Garvin AJ
Mod Pathol; 1996 Mar; 9(3):238-44. PubMed ID: 8685221
[TBL] [Abstract][Full Text] [Related]
47. Impact of the MTHFR C677T polymorphism on risk of Wilms tumor: case-control study.
Ferrara M; Capozzi L; Russo R
J Pediatr Hematol Oncol; 2009 Apr; 31(4):256-8. PubMed ID: 19346876
[TBL] [Abstract][Full Text] [Related]
48. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor.
Williams RD; Al-Saadi R; Natrajan R; Mackay A; Chagtai T; Little S; Hing SN; Fenwick K; Ashworth A; Grundy P; Anderson JR; Dome JS; Perlman EJ; Jones C; Pritchard-Jones K
Genes Chromosomes Cancer; 2011 Dec; 50(12):982-95. PubMed ID: 21882282
[TBL] [Abstract][Full Text] [Related]
49. Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor.
Tamimi Y; Dietrich K; Stone K; Grundy P
Mutat Res; 2006 Oct; 601(1-2):46-50. PubMed ID: 16814811
[TBL] [Abstract][Full Text] [Related]
50. The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children.
Wang J; Lou S; Huang X; Mo Y; Wang Z; Zhu J; Tian X; Shi J; Zhou H; He J; Ruan J
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32083300
[TBL] [Abstract][Full Text] [Related]
51. Assessment of somatic mutations in urine and plasma of Wilms tumor patients.
Miguez ACK; Barros BDF; de Souza JES; da Costa CML; Cunha IW; Barbosa PNVP; Apezzato MLP; de Souza SJ; Carraro DM
Cancer Med; 2020 Aug; 9(16):5948-5959. PubMed ID: 32592321
[TBL] [Abstract][Full Text] [Related]
52. Association Between TP53 Mutation and Prognosis in Wilms Tumor: A Meta-Analysis.
Lizhi L; Rongdong H; Shaohua H; Yingquan K; Huihuang X; Shan L; Kunbin T; Di X
Fetal Pediatr Pathol; 2021 Dec; 40(6):653-662. PubMed ID: 32066305
[No Abstract] [Full Text] [Related]
53. Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution.
Rastegar B; Andersson N; Petersson A; Karlsson J; Chattopadhyay S; Valind A; Jansson C; Durand G; Romerius P; Jirström K; Holmquist Mengelbier L; Gisselsson D
Clin Cancer Res; 2023 Jul; 29(14):2668-2677. PubMed ID: 37140929
[TBL] [Abstract][Full Text] [Related]
54.
Liu P; Zhuo Z; Li W; Cheng J; Zhou H; He J; Zhang J; Wang J
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610160
[TBL] [Abstract][Full Text] [Related]
55. A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study.
Armstrong AE; Gadd S; Huff V; Gerhard DS; Dome JS; Perlman EJ
PLoS One; 2018; 13(12):e0208936. PubMed ID: 30543698
[TBL] [Abstract][Full Text] [Related]
56. Absence of the TRIP13 c.1060C>T Mutation in Wilms Tumor Patients From Pakistan.
Rashid MU; Naeemi H; Qazi AQ; Muhammad N; Ahmad M; Akhtar N; Rahman N
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e128-e131. PubMed ID: 31574018
[TBL] [Abstract][Full Text] [Related]
57. Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.
Sagne C; Marcel V; Bota M; Martel-Planche G; Nobrega A; Palmero EI; Perriaud L; Boniol M; Vagner S; Cox DG; Chan CS; Mergny JL; Olivier M; Ashton-Prolla P; Hall J; Hainaut P; Achatz MI
Carcinogenesis; 2014 Apr; 35(4):807-15. PubMed ID: 24336192
[TBL] [Abstract][Full Text] [Related]
58. TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia.
Wegert J; Vokuhl C; Ziegler B; Ernestus K; Leuschner I; Furtwängler R; Graf N; Gessler M
J Pathol Clin Res; 2017 Oct; 3(4):234-248. PubMed ID: 29085664
[TBL] [Abstract][Full Text] [Related]
59. PIN3 duplication may be partially responsible for TP53 haploinsufficiency.
Winiecka-Klimek M; Szybka M; Rieske P; Piaskowski S; Bienkowski M; Walczak M; Pacholczyk M; Rostkowski M; Zieba J; Banaszczyk M; Hulas-Bigoszewska K; Peciak J; Pawliczak R; Stoczynska-Fidelus E
BMC Cancer; 2014 Sep; 14():669. PubMed ID: 25223755
[TBL] [Abstract][Full Text] [Related]
60. Review of prognostic and predictive aspects of mutated TP53 in Wilms' tumor biology with morphological report and molecular analysis of 37-year-old man's nephroblastoma.
Wincewicz A; Kowalik A; Zięba S; Kopczyński J; Góźdź S; Sulkowski S
Pol J Pathol; 2016; 67(4):307-312. PubMed ID: 28547957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
